EPISODE · Feb 15, 2026 · 4 MIN
今天3分钟我们来聊聊糖尿病治疗改写？2026细胞疗法来了
from 源于细胞BioInsid的个人播客
全球首个iPSC胰岛细胞疗法VX880预计2026年6月上市，为1型糖尿病患者带来“细胞重建”新希望，可恢复胰岛功能，但需警惕免疫抑制剂风险与高昂费用。 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊糖尿病治疗改写？2026细胞疗法来了
0:00
4:59
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 4 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on February 15, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!